| Literature DB >> 35650218 |
Pietro Feltri1, Luca Solaro2, Alessandro Di Martino3, Christian Candrian1,4, Costantino Errani5, Giuseppe Filardo4,6.
Abstract
To understand the potential and limitations of the different available surgical techniques used to treat large, long-bone diaphyseal defects by focusing on union, complication, re-intervention, and failure rates, summarizing the pros and cons of each technique. A literature search was performed on PubMed, Web of Science, and Cochrane databases up to March 16th, 2022; Inclusion criteria were clinical studies written in English, of any level of evidence, with more than five patients, describing the treatment of diaphyseal bone defects. The primary outcome was the analysis of results in terms of primary union, complication, reintervention, and failure rate of the four major groups of techniques: bone allograft and autograft, bone transport, vascularized and non-vascularized fibular graft, and endoprosthesis. The statistical analysis was carried out according to Neyeloff et al., and the Mantel-Haenszel method was used to provide pooled rates across the studies. The influence of the various techniques on union rates, complication rates, and reintervention rates was assessed by a z test on the pooled rates with their corresponding 95% CIs. Assessment of risk of bias and quality of evidence was based on Downs and Black's "Checklist for Measuring Quality" and Rob 2.0 tool. Certainty of yielded evidence was evaluated with the GRADE system. Seventy-four articles were included on 1781 patients treated for the reconstruction of diaphyseal bone defects, 1496 cases in the inferior limb, and 285 in the upper limb, with trauma being the main cause of bone defect. The meta-analysis identified different outcomes in terms of results and risks. Primary union, complications, and reinterventions were 75%, 26% and 23% for bone allografts and autografts, 91%, 62% and 19% for the bone transport group, and 78%, 38% and 23% for fibular grafts; mean time to union was between 7.8 and 8.9 months in all these groups. Results varied according to the different aetiologies, endoprosthesis was the best solution for tumour, although with a 22% failure rate, while trauma presented a more composite outcome, with fibular grafts providing a faster time to union (6.9 months), while cancellous and cortical-cancellous grafts caused less complications, reinterventions, and failures. The literature about this topic has overall limited quality. However, important conclusions can be made: Many options are available to treat critical-size defects of the diaphysis, but no one appears to be an optimal solution in terms of a safe, satisfactory, and long-lasting outcome. Regardless of the bone defect cause, bone transport techniques showed a better primary union rate, but bone allograft and autograft had fewer complication, reintervention, and failure rates than the other techniques. The specific lesion aetiology represents a critical aspect influencing potential and limitations and therefore the choice of the most suitable technique to address the challenging large diaphyseal defects.Entities:
Mesh:
Year: 2022 PMID: 35650218 PMCID: PMC9160061 DOI: 10.1038/s41598-022-12140-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1PRISMA (Preferred Reporting Items for Systematic Meta-Analyses) flowchart of the study selection process.
Figure 2Graphic representation of the trend, over the years, of the four major groups of techniques.
Summary of all the studies characteristics. VFG (vascularised fibular graft), NVFG (non-vascularised fibular graft), BTON (Bone Transport Over Intramedullary Nail), PMMA (Poly Methyl Methacrylate), IMT (Induced Membrane Technique).
| Article | Study design | F-UP | N° of PTS (M:F) | Aetiology | Technique | Defect (CM) |
|---|---|---|---|---|---|---|
| Haque[ | Case series | NA | 20 (16:4) | Trauma | Hemicylindrical sliding bone graft, bone graft, tibio-fibular synostosis | 3.5 |
| Christian[ | Case series | 27 | 8 (8:0) | Trauma | Massive autogenous cancellous bone graft | 10.2 |
| Banic[ | Case series | 17.3 | 7 (NA) | Trauma | VFG: double strut VFG + cancellous bone graft | 11.6 |
| Herte[ | Case series | 32 | 12 (9:3) | Trauma, Tumor | VFG + cancellous bone graft | 12 |
| Abudu[ | Case series | 65 | 18 (14:4) | Tumor | Endoprosthesis | 21 |
| Khan[ | Case series | 90 | 8 (5:3) | Trauma | VFG + cancellous bone graft | 5 |
| Hsu[ | Case series | 36 | 30 (16:4) | Tumor | VFG + corticocancellous bone graft | 12.9 |
| Barbieri[ | Case series | NA | 12 (10:2) | Trauma | Corticocancellous bone autograft | NA |
| Polyzois[ | Case series | 38 | 42 (29:13) | Trauma, Osteomyelitis, Congenital, Nonunion | Ilizarov distraction osteogenesis | 6 |
| Smrke[ | Case series | 115 | 20 (17:3) | Infection | Ilizarov distraction osteogenesis, Ljubljana traction | 10.4 |
| Ueng[ | Case series | 58 | 15 (14:1) | Nonunion | Corticocancellous bone autograft, VFG | NA |
| Ring[ | Case series | 31 | 15 (9:6) | Nonunion | Autogenous bone graft | 3 |
| Morsi[ | Case series | 32.5 | 7 (6:1) | Nonunion | NVFG | 4.7 |
| Taha[ | Case series | 59.9 | 8 (6:2) | Tumor, Trauma, Osteomyelitis | NVFG | 10.4 |
| Aldlyami[ | Case series | 107 | 35 (22:13) | Tumor | Endoprosthesis | 19 |
| Chang[ | Case series | 24 | 14 (NA) | Tumor | VFG + intercalary allograft | NA |
| El-Mowafi[ | Case series | 27 | 16 (12:4) | Infection | Ilizarov distraction osteogenesis | 6.4 |
| Ahlmann[ | Case series | 21.6 | 6 (4:2) | Tumor | Endoprosthesis | 12.3 |
| Jones[ | RCT | 12 | 30 (NA) | Trauma | Allograft + BMP-2, autograft | 3.8 |
| Kocaoglu[ | Case series | 47.3 | 13 (8:5) | Osteomyelitis | Bone transport over intramedullary nail (BTON) | 10 |
| Catagni[ | Case series | 70.8 | 7 (6:1) | Osteomyelitis, Trauma, Infection | Ilizarov distraction osteogenesis | 15.1 |
| Moran[ | Case series | 36 | 7 (5:2) | Tumor | Capanna technique | 13 |
| Oh[ | Case series | NA | 12 (12:0) | Osteomyelitis | Bone transport over intramedullary nail (BTON) | 5.8 |
| Chaddha[ | Case series | 23.5 | 25 (25:0) | Trauma | Ilizarov distraction osteogenesis | 8.9 |
| Gupta[ | Prospective | NA | 23 (15:8) | Nonunion | Modified Nicoll's technique | 4.7 |
| Hutson[ | Case series | 58 | 18 (13:5) | Trauma | Bone transport | 9.4 |
| Prasarn[ | Case series | 60 | 15 (9:6) | Nonunion | Tricortical iliac crest bone graft | 2.1 |
| Li[ | Case series | 34.1 | 11 (5:6) | Tumor | Capanna technique | 12.1 |
| Liodakis[ | Case series | 61.2 | 22 (17:5) | Trauma | Monorail technique | 7.4 |
| Ruggieri[ | Case series | 29 | 24 (11:13) | Tumor | Modular intramedullary segmental defect fixation system | 10 |
| Li[ | Case series | 27.7 | 7 (4:3) | Tumor | Capanna technique | 10.6 |
| Karger[ | Case series | NA | 84 (79:5) | Trauma | Induced membrane technique | 6.8 |
| De Gauzy (2012) | Case series | NA | 27 (17:10) | Trauma | Induced membrane technique, bone transport, autograft, VFG | NA |
| Puri[ | Case series | 34 | 32 (24:8) | Tumor | Resection, irradiation and reimplantation of bone | 19 |
| Toros[ | Case series | 37 | 6 (3:3) | Nonunion | VFG | NA |
| Farfalli[ | Case series | 73 | 26 (13:13) | Tumor | Intercalary allograft | NA |
| Borzunov[ | Case–control | NA | 83 (54:29) | Trauma, Osteomyelitis, Congenital, Tumor | Ilizarov distraction osteogenesis, gradual tibialisation of the fibula | 12.8 |
| Prejbeanu[ | Case–control | 30 | 12 (6:6) | Tumor | Intramedullary nail + PMMA | 9 |
| Xu (2013) | Case series | 29 | 30 (21:9) | Nonunion | Ilizarov distraction osteogenesis | 6.4 |
| El Ghaffar[ | Prospective | 24 | 12 (12:0) | Trauma | Two-stage reconstruction: debridement + pin, then corticocancellous bone grafting | NA |
| Saka[ | Case series | 32 | 8 (5:3) | Nonunion | (Modified Nicoll's technique) | 1.8 |
| Schuh[ | Case series | 52 | 53 (26:27) | Tumor | VFG, NVFG | NA |
| Le Thua[ | Case series | NA | 26 (18:8) | Trauma, Osteomyelitis, Nonunion | VFG | 10.8 |
| Ajmera[ | Case series | 15 | 25 (25:0) | Trauma | Bone transport | 5.5 |
| Bernstein[ | Case series | 33 | 58 (39:19) | Trauma | Ilizarov distraction osteogenesis, bone transport over intramedullary nail (BTON) | 5.3 |
| Marais[ | Case series | 28 | 7 (NA) | NA | Bone transport | 7 |
| Davis[ | Case series | 42 | 7 (5:2) | Nonunion | Staged reconstruction technique (allograft + IM nail) | 4.9 |
| Gupta[ | Case series | 21.5 | 9 (7:2) | Nonunion | Induced membrane technique | 5.2 |
| Benevenia[ | Case series | 14 | 41 (27:14) | Tumor | Endoprosthesis | NA |
| Sadek[ | Case–control | NA | 30 (24:6) | Nonunion | Two-steps debridment + iliac graft vs one-step Ilizarov distraction osteogenesis | 4.6 |
| Huang[ | Case series | 9 | 16 (6:10) | Tumor | Intercalary endoprosthesis | 10.2 |
| Tong[ | Case–control | 25.3 | 39 (30:9) | Osteomyelitis | Induced membrane technique, Ilizarov distraction osteogenesis | 6.8 |
| Zoller[ | Case series | 18.3 | 9 (8:1) | Trauma | Induced membrane technique | 6.4 |
| Ferchaud[ | Case series | 62 | 7 (NA) | Trauma | Bone transport over intramedullary nail (BTON) | 7.2 |
| Tedesco[ | Case series | 39 | 6 (3:3) | Tumor | Endoprosthesis | NA |
| Attias[ | Case series | 55 | 17 (14:3) | Trauma | Cancellous bone graft (Titanium mesh cage) | 8.4 |
| Cano-Luis[ | Case series | 166.8 | 14 (13:1) | Trauma | VFG | NA |
| Zaho[ | Case series | 8.6 | 9 (4:5) | Tumor | Endoprosthesis | 7.8 |
| Errani[ | Case series | 96 | 81 (56:25) | Tumor | Massive bone allograft + VFG | 15.9 |
| Davda[ | Case series | NA | 10 (8:2) | Nonunion | Bone transport over intramedullary nail (BTON) | 7 |
| Meselhy[ | Prospective | 40.5 | 14 (10:4) | Osteomyelitis, Trauma | Ilizarov distraction osteogenesis | 13.2 |
| Catagni[ | Case–control | 43.3 | 86 (77:9) | Trauma, Nonunion, Osteomyelitis | Bifocal fibular transfer, trifocal fibular transfer | 13 |
| Liu[ | Case series | 65.1 | 15 (9:6) | Tumor | VFG + autograft | 19.8 |
| Salunke[ | Case series | 30.9 | 28 (NA) | Tumor | NVFG, extracorporeal radiotherapy autograft | 14.9 |
| Zheng[ | Case series | 13.7 | 49 (23:26) | Tumor | Endoprosthesis | 9.2 |
| Ma[ | Case series | 19.1 | 51 (32:19) | Trauma | Cancellous wrap + titanium mesh cage/line mesh/line-binding, IMT | 5.9 |
| Bas[ | Case series | 25.7 | 40 (26:14) | Trauma, Nonunion | Bone transport over intramedullary nail (BTON) | 7.1 |
| Lu[ | Case series | 25.8 | 12 (10:2) | Trauma, Nonunion | Bone transport | 6.7 |
| Choi[ | Case series | 18 | 8 (4:4) | Trauma | Autologous iliac graft | 2.6 |
| Lotzien[ | Case series | 33.1 | 31 (30:1) | Nonunion | Induced membrane technique | 8.3 |
| Huang (2021) | Comparative | 29.1 | 77 (54:23) | Trauma, Osteomyelitis | Bone transport + graft + internal fixation / bone transport | 13.5 |
| Wang[ | Case series | NA | 42 (17:25) | Trauma | Induced membrane technique | 6.3 |
| Büyükdoğan[ | Case series | 17 | 22 (15:7) | Tumor | Endoprosthesis | 10 |
| Liu[ | Case series | 28.2 | 12 (10:2) | Osteomyelitis | Bone transport | 5.1 |
Summary of bone defect causes.
| Treatment groups | |||||
|---|---|---|---|---|---|
| Causes of bone defect | Fibular graft (%) | Bone graft (%) | Bone transport (%) | Endoprosthesis (%) | Various techniques (%) |
| Tumor | 73.1 | 18.8 | 1.0 | 100 | 0 |
| Trauma | 17.1 | 53.7 | 55.6 | 0 | 75.8 |
| Nonunion | 6.7 | 23.9 | 20.1 | 0 | 24.2 |
| Infection | 3.1 | 3.6 | 21.9 | 0 | 0 |
| Congenital defect | 0 | 0 | 1.4 | 0 | 0 |
Summary of all outcomes.
| Outcomes | |||||
|---|---|---|---|---|---|
| Groups of treatment | Primary union | Time to union | Complication | Reintervention | Failure |
Bone allograft and autograft | 75% (C.I. 72%–78%) | 7.8 months (1–27 months) | 26% (C.I. 22%–30%) | 23% (C.I. 19%–28%) | 8% (C.I. 6%–11%) |
Bone transport | 91% (C.I. 89%–93%) | 8.9 months (3–52 months) | 62% (C.I. 59%–65%) | 19% (C.I. 16%–22%) | 8% (C.I. 6%–10%) |
Vascular and non-vascular fibular graft | 78% (C.I. 73%–82%) | 8.3 months (2–33 months) | 38% (C.I. 33%–43%) | 23% (C.I. 19%–28%) | 8% (C.I. 5%–12%) |
Endoprosthesis | NA | NA | 26% (C.I. 21%–32%) | 20% (C.I. 15%–28%) | 22% (C.I. 18%–28%) |
Summary of trauma studies outcomes.
| Trauma outcomes | |||||
|---|---|---|---|---|---|
| Groups of treatment | Primary union | Time to union | Complication | Reintervention | Failure |
Bone allograft and autograft | 89% (C.I. 85%–91%) | 8.9 months (1–27 months) | 22% (C.I. 18%–28%) | 20% (C.I. 15%–27%) | 1% (C.I. 1%–3%) |
Bone transport | 90% (C.I. 85%–93%) | 9.8 months (4–22 months) | 69% (C.I. 64%–74%) | 42% (C.I. 34%–51%) | NA |
Vascular and non-vascular Fibular graft | 89% (C.I. 76%–96%) | 6.9 months (2–33 months) | 40% (C.I. 27%–56%) | 41% (C.I. 27%-56%) | 9% (C.I. 3%–24%) |
Summary of tumor studies outcomes.
| Tumor outcomes | |||||
|---|---|---|---|---|---|
| Groups of treatment | Primary union | Time to union | Complication | Reintervention | Failure |
Bone allograft and autograft | 82% (C.I. 73%–88%) | NA | 39% (C.I. 31%–48%) | 31% (C.I. 23%–40%) | NA |
Vascular and non-vascular fibular graft | 74% (C.I. 68%–79%) | 8.4 months (2–27 months) | 38% (C.I. 33%–44%) | 26% (C.I. 21%–31%) | 13% (C.I. 9%–19%) |
endoprosthesis | NA | NA | 26% (C.I. 21%–32%) | 20% (C.I. 15%–28%) | 22% (C.I. 18%–28%) |
Summary of all complications.
| Groups of treatment | |||||
|---|---|---|---|---|---|
| Complications | Fibular graft | Bone graft | Bone transport | Endoprosthesis | Various techniques |
| Fracture | 23.9% (31) | 4.9% (9) | 3.8% (16) | 11.3% (8) | 2.7% (1) |
| Infection | 11.5% (15) | 28.0% (51) | 24.7% (105) | 7.1% (5) | 10.8% (4) |
| Donor site morbidity | 2.3% (3) | 2.7% (5) | 1.4% (6) | 0% (0) | 0% (0) |
| Nonunion | 16.7% (22) | 25.3% (46) | 9.6% (41) | 0% (0) | 21.6% (8) |
| Limb deformity | 6.2% (8) | 3.3% (6) | 7.5% (32) | 2.9% (2) | 13.5% (5) |
| Vascular injury | 0.8% (1) | 1.6% (3) | 0.7% (3) | 0% (0) | 0% (0) |
| Flap necrosis | 2.3% (3) | 4.4% (8) | 0% (0) | 0% (0) | 8.2% (3) |
| Mechanical problems | 4.6% (6) | 8.2% (15) | 4.7% (20) | 64.3% (36) | 0% (0) |
| Wound deiscency | 11.5% (15) | 3.3% (6) | 6.6% (28) | 2.9% (2) | 0% (0) |
| Nerve palsy | 2.3% (3) | 0.5% (1) | 4.0% (17) | 4.3% (2) | 13.5% (5) |
| Hematoma | 0% (0) | 1.1% (2) | 0.9% (4) | 0% (0) | 0% (0) |
| Osteomyelitis | 0.8% (1) | 0% (0) | 1.6% (7) | 0% (0) | 0% (0) |
| Pseudoarthrosis | 0.8% (1) | 0% (0) | 2.6% (11) | 0% (0) | 0% (0) |
| Rom limitation | 2.3% (3) | 3.3% (6) | 15.3% (65) | 0% (0) | 29.7% (11) |
| Chronic pain | 3.9% (5) | 0% (0) | 2.4% (10) | 0% (0) | 0% (0) |
| Implant allergy | 0% (0) | 0% (0) | 0.5% (2) | 0% (0) | 0% (0) |
| Limb length Discrepancy | 4.6% (6) | 3.8% (7) | 8.2% (35) | 2.9% (2) | 0% (0) |
| Delayed union | 5.4%(7) | 9.3% (17) | 6.1% (26) | 4.3% (3) | 0% (0) |
Figure 3Risk of bias of all the included studies, evaluated in accordance with the “Downs and Black’s tool for assessing the risk of bias”.
Figure 4Risk of bias of all the included studies, evaluated in accordance with the Rob 2.0 tool.